8-K: The Marquie Group Secures $1.25 Million Equity Commitment from MacRab LLC

The Marquie Group has entered into an agreement with MacRab LLC for a potential equity investment of up to $1.25 million, with shares to be purchased at a discount.

Summary

• The Marquie Group has entered into an Equity Commitment Agreement with MacRab LLC, where MacRab will purchase up to $1,250,000 of the company's common stock.
• The purchase price will be at a 20% discount to the average of the two lowest volume-weighted average prices during the five trading days after the clearing date.
• MacRab's purchases are capped at 4.99% of the company's outstanding shares.
• The company is registering 1,250,000,000 shares for potential issuance under this agreement, but the actual number of shares issued could be significantly higher, potentially reaching 15,000,000,000, due to a minimum purchase price of $0.0001 per share.
• Wilson Davis & Co., Inc. will act as broker-dealer for MacRab, receiving a 4.5% commission on sales and reimbursement for expenses up to $10,000.
• The company controls the timing and amount of stock sales to MacRab.
• The agreement includes conditions such as the effectiveness of the registration statement, accuracy of representations, and no material adverse events.
• The company has the right to terminate the agreement at any time without penalty.
• MacRab is prohibited from short-selling the company's stock during the agreement period.

Sentiment

Score: 4

Explanation: The agreement provides needed capital, but the potential for massive dilution and the discounted share price are significant negatives. The company's control over the timing of sales is a positive, but the overall impact is likely to be negative for existing shareholders.

Positives

• The agreement provides The Marquie Group with access to up to $1.25 million in capital.
• The company retains control over the timing and amount of stock sales.
• The company has the option to terminate the agreement at any time without penalty.
• MacRab is prohibited from short-selling the company's stock, which could help stabilize the share price.

Negatives

• The potential issuance of up to 15,000,000,000 shares could significantly dilute existing shareholders.
• The 20% discount on share purchases could negatively impact the company's valuation.
• The company is responsible for broker fees and expenses.
• The agreement is subject to several conditions that must be met for the sales to occur.

Risks

• The potential for significant share dilution could negatively impact the stock price.
• The company's ability to meet the conditions of the agreement is crucial for accessing the committed capital.
• The market price of the company's stock could be volatile due to the potential for large share issuances.
• The agreement could be terminated by the company at any time, which could impact the company's financial planning.

Future Outlook

The company intends to use the funds from this agreement for general corporate purposes. The company will control the timing and amount of any sales of its common stock to MacRab.

Management Comments

• The company will control the timing and amount of any sales of our common stock to MacRab.

Industry Context

This type of equity commitment agreement is a common method for smaller companies to raise capital. It allows for flexible funding, but can also lead to significant share dilution if not managed carefully. The use of a broker-dealer to facilitate the sales is also a standard practice.

Comparison to Industry Standards

• Similar equity commitment agreements are often seen with small-cap and micro-cap companies seeking flexible funding options.
• The 20% discount is within the range of discounts offered in similar agreements, but the potential for significant dilution is a notable risk.
• The use of a broker-dealer like Wilson Davis & Co. is standard practice for these types of transactions.
• The 4.5% commission is within the typical range for such agreements.
• The 4.99% ownership cap is a common measure to avoid triggering certain regulatory requirements.

Stakeholder Impact

• Shareholders may experience significant dilution due to the potential issuance of a large number of new shares.
• The company will have access to additional capital, which could benefit its operations and growth.
• The agreement could lead to increased volatility in the company's stock price.

Next Steps

• The company needs to file a registration statement with the SEC for the resale of the shares.
• The company needs to secure the listing or quotation of the shares on the Principal Market.
• The company will need to manage the timing and amount of stock sales to MacRab.

Key Dates

Keywords

equity commitment, common stock, share dilution, capital raise, discounted shares, MacRab LLC, Wilson Davis & Co., registration statement